P-588 Tumor responsiveness to combined modality therapy (CMT) is highly significant predictor of survival for patients with locally advanced non-small cell lung cancer(LANSCLC)

✍ Scribed by Kim, Dong Wook; Shyr, Yu; Akerley, Wallace L.; Choy, Hak

• Book ID: 118572283
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 360 KB
• Volume: 41
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(03)92555-4